Guggenheim raised the price target for the CVS Health Corporation (NYSE:CVS) stock from “a Buy” to “a Neutral”. The rating was released on March 17, 2021. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $72. The stock was initiated by SVB Leerink, who disclosed in a research note on July 01, 2020, to Mkt Perform and set the price objective to $72. In their research brief published May 14, 2020, Credit Suisse analysts upgraded the CVS Health Corporation stock from Neutral to Outperform with a price target of $75.
Historical Earnings Surprises and Revenue Forecasts
Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price to increase when earnings exceed market expectations and progressively decrease when earnings do not meet expectations. The firm reported an earnings per share (EPS) of $1.3 during the last quarter as opposed to a consensus estimate of $1.24, which indicates the company beat its estimate by $0.06, which implies that the company surprised the market by 4.80%. It appears that the average earnings per share estimate for the current quarter (ending in Mar 2021) is $1.71. This is an average of 22 analysts’ earnings, where the high earnings per share estimate is $1.8 and the low earnings per share estimate is $1.49. According to 19 analyst estimates, an average revenue estimate of $68.39B is projected for the current quarter with a high revenue estimate of $69.93B and a low estimate of $66.89B.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of CVS Health Corporation (NYSE:CVS) raised 4.41% to close Tuesday’s market session at $81.12, higher as compared to yesterday’s close. The stock price fluctuated between $78.75 and $81.35 throughout the trading session with the volume trading being 19497324 shares, which represented a significant variation when compared to the three months average volume of 6.76 million shares. The firm’s stock price fluctuated 8.00% within the last five trades and 8.10% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 44.62% in the last 6 months and 12.93% was added to its value over the previous 3 months. CVS stock is trading at a margin of 7.48%, 10.11% and 19.77% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, CVS deals in the Healthcare domain. The stock is trading 3.71 percent below its 52-week high and 46.53 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 34.44. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does CVS Health Corporation’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 4.60 percent and the profit margin is 2.70 percent, and the company has reported a gross margin of 39.00 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $106.43 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for CVS Health Corporation (NYSE:CVS) is 14.82. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 10.01. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 0.40 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.53, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.20 percent of CVS Health Corporation shares are owned by insiders, and 78.50 percent are held by financial institutions. Moriarty Thomas M, the EVP & General Counsel at CVS Health Corporation (CVS) has sold 103,423 shares of firm on Apr 21 at a price of $77.00 against the total amount of $7.96 million. In another inside trade, Moriarty Thomas M, EVP & General Counsel of CVS Health Corporation (NYSE:CVS) sold 62,943 shares of the firm on Mar 29 for a total worth of $4.79 million at a price of $76.15. An inside trade which took place on Mar 26, EVP & Chief Operating Officer of CVS Health Corporation Roberts Jonathan C sold 73,433 shares of firm against total price of $5.47 million at the cost of $74.49 per share.